Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Biochem ; 119(4): 3044-3057, 2018 04.
Article in English | MEDLINE | ID: mdl-29058791

ABSTRACT

This study aimed to investigate the PD-1/ PD-L1 signaling pathway and its effects the activation of microglia/macrophage and balancing T cell subsets in cryptococcal meningitis (CM). A total of 126 CM patients and 126 healthy individuals were recruited for the study. The CM patients were treated with amphotericin B (AmB). Seventy five C57BL/6 mice were grouped into the normal control, CM model, CM + AmB, sham, and CM + PD-1 antibodies (Ab) groups. CD4+ and CD8+ T cells as well as microglia/macrophages were analyzed by means of flow cytometry. Ionized calcium-binding adaptor molecule 1 (Ibal) expression was detected using western blotting and immunohistochemistry techniques. And the expression of Rab5 and Rab11 were detected using an immunofluorescence assay. Both PD-1 and PD-L1 mRNA and protein expression among the mice in the study were evaluated by qRT-PCR and western blotting methods. Compared to the CM model group, the CM + AmB and CM + PD-1 Ab groups exhibited increased levels of Th1 cytokines and chemokines expression, and reduced levels of Th2 cytokines expressions. Elevated cell purity and viability of CD4+ T cell were recorded as well as increases in microglia, however, there were reductions in the number of CD8+ T cells. Depleted expressions of Ibal, Rab5, and Rab11 as well as reduced mRNA expressions of PD-1 and PD-L1 in CD4+ , microglia, and macrophage cells. The findings suggested that suppression of the PD-1/PD-L1 signaling pathway restricts the proliferation of CM by down-regulating the expressions of Th2 cells and suppressing microglia and macrophage activation.


Subject(s)
Amphotericin B/administration & dosage , Antibodies/administration & dosage , Antifungal Agents/administration & dosage , B7-H1 Antigen/metabolism , Macrophages/drug effects , Meningitis, Cryptococcal/drug therapy , Microglia/drug effects , Programmed Cell Death 1 Receptor/metabolism , Adolescent , Adult , Aged , Amphotericin B/pharmacology , Animals , Antibodies/pharmacology , Antifungal Agents/pharmacology , B7-H1 Antigen/genetics , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/metabolism , Disease Models, Animal , Drug Administration Schedule , Female , Humans , Male , Meningitis, Cryptococcal/genetics , Meningitis, Cryptococcal/immunology , Meningitis, Cryptococcal/metabolism , Mice , Mice, Inbred C57BL , Middle Aged , Programmed Cell Death 1 Receptor/genetics , Th1 Cells/drug effects , Th1 Cells/immunology , Th2 Cells/drug effects , Th2 Cells/immunology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...